Your Search Returned 32 tagged news reports
The former tend to drive prices down constantly, innovating all the while in order to make a profit; the latter, by contrast, typically enjoy monopolies that allow them to push up prices without offering anything more in return. Here's another great
Then, place the mixture into an impermeable container that will not let the contents escape under any conditions. Using a jar with a lid or a plastic Ziploc bag are wise choices. Finally, dispose of the container right into the household trash bag...
Earning Catalysts That Could Push This Biotech Even Higher Sherrie is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited...The company is scheduled to report earnings in two
Imagine a world where all the vitamins, minerals, herbs, extracts, compounds, powders, and probiotics that are so freely available at any health food store and at many grocery stores were suddenly made illegal so they could be turned into
Contact Information Available for logged-in reporters only Description To develop new treatment options for patients with SD who failed available options, a Mount Sinai team is examining the central mechanisms of action of a novel oral medication,
Under the agreement, Jazz will develop Concert's deuterium-modified sodium oxybate (D-SXB) compounds, including C-10323, and will have worldwide commercial rights to C-10323 as well as principal responsibility for ongoing development activities.
Jazz shares are trading up more than 30% year-to-date based on Xyrem's strength, but generic competition looms...Restructuring efforts Near the end of 2011, Jazz had two products: narcolepsy treatment Xyrem and obsessive compulsive disorder treatment
David Frum, a CNN contributor, is a contributing editor at Newsweek and The Daily Beast. He is the author of eight books, including a new novel "Patriots" and his post-election e-book, "Why Romney Lost."...Bush from 2001 to 2002. (CNN) -- Red wine in
Earlier this week, a federal appeals court panel overturned the conviction of a former sales rep for allegedly encouraging doctors to prescribe a drug on an off-label basis, ruling that his conviction violated his First Amendment rights. The FDA may
The new patent entitled Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy provides protection until December 2019. Jazz Pharmaceuticals chairman and chief executive officer Bruce Cozadd said, "